Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toujeo vs Lantus in insulin-naïve T2DM (EDITION AP)
NCT02855684Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Aug 2016; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02855684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02855684.